These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23082123)

  • 21. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
    Jefferson T; Jones M; Doshi P; Spencer EA; Onakpoya I; Heneghan CJ
    BMJ; 2014 Apr; 348():g2545. PubMed ID: 24811411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility.
    Bush KA; McAnulty J; McPhie K; Reynolds R; Boomer M; Clarkson LM; Quaine J; Dwyer DE;
    Commun Dis Intell Q Rep; 2004; 28(3):396-400. PubMed ID: 15574064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza.
    Khazeni N; Bravata DM; Holty JE; Uyeki TM; Stave CD; Gould MK
    Ann Intern Med; 2009 Oct; 151(7):464-73. PubMed ID: 19652173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oseltamivir in the management of influenza.
    Oxford J
    Expert Opin Pharmacother; 2005 Nov; 6(14):2493-500. PubMed ID: 16259580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outbreaks of influenza-like illness in care homes in the East of England: impact of variations in neuraminidase inhibitor provision.
    Yip JLY; Kapadia S; Ahmed A; Millership S
    Public Health; 2018 Sep; 162():98-103. PubMed ID: 29990618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
    Shun-Shin M; Thompson M; Heneghan C; Perera R; Harnden A; Mant D
    BMJ; 2009 Aug; 339():b3172. PubMed ID: 19666987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid on-site molecular Point of Care Testing during influenza outbreaks in aged care facilities improves antiviral use and reduces hospitalisation.
    Escarate E; Jones CG; Clarke E; Clark P; Norton S; Bag S; Kok J; Dwyer DE; Lindley RI; Booy R
    Aust N Z J Public Health; 2022 Dec; 46(6):884-888. PubMed ID: 36190193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid Detection of Influenza Outbreaks in Long-Term Care Facilities Reduces Emergency Room Visits and Hospitalization: A Randomized Trial.
    Temte JL; Checovich MM; Barlow S; Shult PA; Reisdorf E; Haupt TE; Hamrick I; Mundt MP
    J Am Med Dir Assoc; 2023 Dec; 24(12):1904-1909. PubMed ID: 37421970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of prophylactic antivirals and care home characteristics associated with influenza in care homes with confirmed outbreaks.
    Shah A; Harries AD; Cleary P; McGivern M; Ghebrehewet S
    Public Health; 2019 Dec; 177():48-56. PubMed ID: 31533085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of an H1N1 outbreak in a correctional facility in central Taiwan.
    Chao WC; Liu PY; Wu CL
    J Microbiol Immunol Infect; 2017 Apr; 50(2):175-182. PubMed ID: 26051221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan.
    Chang YM; Li WC; Huang CT; Huang CG; Tsao KC; Cheng YH; Chiang SL; Yang SY; Chen CH; Huang YC
    J Hosp Infect; 2008 Jan; 68(1):83-7. PubMed ID: 17945389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oseltamivir in neonates, infants and young children: a focus on clinical pharmacology.
    Karadag-Oncel E; Ceyhan M
    Infect Disord Drug Targets; 2013 Feb; 13(1):15-24. PubMed ID: 23675923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.
    Peters PH; Gravenstein S; Norwood P; De Bock V; Van Couter A; Gibbens M; von Planta TA; Ward P
    J Am Geriatr Soc; 2001 Aug; 49(8):1025-31. PubMed ID: 11555062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
    Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.
    Sugaya N; Ohashi Y
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2575-82. PubMed ID: 20368393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid Detection of Influenza Outbreaks in Long Term Care Facilities Reduces Emergency Room Visits and Hospitalization.
    Temte J; Checovich M; Mundt M; Barlow S; Hamrick I; Reisdorf E
    Ann Fam Med; 2023 Jan; 21(21 Suppl 1):. PubMed ID: 36944078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population.
    Ambrozaitis A; Gravenstein S; van Essen GA; Rubinstein E; Balciuniene L; Stikleryte A; Crawford C; Elliott M; Shult P
    J Am Med Dir Assoc; 2005; 6(6):367-74. PubMed ID: 16286057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oseltamivir use in adolescents and adults: clinical and economic considerations.
    Yin JK; Heron L; Salkeld G; Rashid H; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):53-8. PubMed ID: 23675927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Trujillo A; Barnes J; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2015 Jun; 15(6):654-62. PubMed ID: 25788164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.